Introduction to Animal Models of Tracheal Stenosis

Tracheal stenosis animal models are experimental systems used to simulate upper airway obstruction and increased airway resistance, typically established through surgical ligation, implantation of annular constriction devices, or chemical irritation. In these experiments, sutures or silicone rings are placed at specific sites along the trachea to induce controlled narrowing of the airway lumen, thereby restricting airflow and leading to varying degrees of increased respiratory resistance and impaired ventilation.

Following model establishment, animals exhibit increased respiratory rate, reduced exercise tolerance, and hypoxia‑related physiological changes, accompanied by airway epithelial injury, inflammatory responses, and airway remodeling. This model is widely employed in studies of the pathogenic mechanisms underlying obstructive airway diseases, as well as in the in vivo evaluation of agents that improve respiratory function and exert anti‑inflammatory effects.

Service Advantages of the Aniphe BioLablogical Tracheal Stenosis Animal Model Platform

The Aniphe BioLab tracheal stenosis animal model platform centers on the controlled induction of airway narrowing and the restoration of stable respiratory function, providing a reliable in vivo modeling system for research on obstructive airway diseases and the evaluation of drugs targeting respiratory function.

	The degree of stenosis is controllable. By precisely adjusting the degree of airway stenosis through ligation strength, material diameter, and positioning, graded modeling is achieved.
	The model exhibits high reproducibility. Standardized surgical protocols minimize interpatient variability and ensure consistency in respiratory function parameters.
	Pathological features closely resemble clinical findings. It can reliably reproduce typical pathological changes, including increased airway resistance, impaired ventilation, and chronic hypoxia.
	The process of airway remodeling is well-defined. It allows for the observation of key mechanistic changes, including airway epithelial injury, inflammatory responses, and fibrotic remodeling.
	Multi-dimensional Functional Evaluation System Systematic assessment is achieved by integrating respiratory rate, blood oxygen saturation, and histopathological analysis.

Modeling cycle	8–12 weeks
Laboratory animals	SD rats, New Zealand rabbits, or miniature pigs
Positive drug	Mitomycin C (local antiproliferative agent), triamcinolone acetonide (local glucocorticoid), and 5-fluorouracil (scar‑inhibiting agent) are commonly used positive controls; however, a gold standard is still lacking in this field.
Application areas	Mechanisms of benign tracheal stenosis (fibroblast activation and collagen deposition); screening of anti‑scar agents and locally delivered sustained‑release formulations; evaluation of tracheal stents and drug‑eluting stents; investigation of intervention strategies for acquired stenosis following intubation or mechanical ventilation.

Construction of an Animal Model of Tracheal Stenosis

Following surgical anesthesia, the anterior neck region of the animal is incised to expose the trachea, and a transverse incision is made in the anterior wall between the third and fifth tracheal cartilaginous rings. A rigid nylon brush with a diameter slightly larger than the internal tracheal diameter is then inserted through the incision and advanced distally by approximately 1.5–2.0 cm. Applying constant pressure, the brush is rotated clockwise and moved back and forth 5–10 times to effectively abrade the tracheal mucosal epithelium while injuring the submucosal layer (with slight hemorrhagic exudation at the incision site being desirable). Finally, the trachea and skin are meticulously sutured using absorbable sutures, thereby inducing localized sterile inflammation and scar formation, ultimately resulting in pathological tracheal stenosis.